...
首页> 外文期刊>International Journal of Medical Sciences >In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia
【24h】

In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia

机译:Colistin与替加环素联用对从呼吸机相关性肺炎患者中分离出的耐碳青霉烯类鲍曼不动杆菌的活性

获取原文
           

摘要

Objective: This study investigated the minimum inhibitory concentration (MIC) values and in vitro activity of colistin in combination with tigecycline against carbapenem-resistant Acinetobacter baumannii strains isolated from patients with ventilator-associated pneumonia (VAP) using the E-test method. Methods: A total of 40 A. baumannii strains, identified using the Phoenix Automated Microbiology System (Becton, Dickinson and Co., Franklin Lakes, NJ, USA) by conventional methods, were included in this study. Pulsed-field gel electrophoresis was performed to examine the clonal relationships between isolates. The carbapenem resistance of the strains to colistin and tigecycline was assessed using the E-test method (Liofilchem, Roseto Degli Abruzzi, Italy). The in vitro activity of colistin in combination with tigecycline was evaluated using the fractional inhibitor concentration (FIC) index. Results: While only 1 of 40 A. baumannii strains was determined to be colistin resistant, 6 were tigecycline resistant. The MIC50, MIC90, and MIC intervals of the A. baumannii strains were 0.19, 1.5, and 0.064?4 μg/ml for colistin and 1, 8, and 0.094?256 μg/ml for tigecycline, respectively. No synergistic effect was observed using the FIC index; 8 strains exhibited an indifferent effect and 32 exhibited an antagonist effect. Three of the six strains that were resistant to tigecycline were indifferent; the remaining three were antagonistic. The colistin-resistant strain also exhibited an antagonist effect. Conclusion: In contrast to their synergistic effect against carbapenem-resistant A. baumannii isolates, colistin and tigecycline were highly antagonistic to carbapenem-resistant A. baumannii strains isolated from patients with VAP when the drugs were administered together. Therefore, alternative treatment options should be used during the treatment of VAP attributed to A. baumannii.
机译:目的:本研究使用E-test方法研究了大肠菌素与替加环素联合使用对从呼吸机相关性肺炎(VAP)患者中分离出的耐碳青霉烯类鲍曼不动杆菌的最低抑菌浓度(MIC)值和体外活性。方法:本研究包括通过常规方法使用Phoenix自动微生物系统(Becton,Dickinson和Co.,Franklin Lakes,NJ,美国)鉴定的40株鲍曼不动杆菌。进行脉冲场凝胶电泳以检查分离株之间的克隆关系。使用E-test方法(Liofilchem,Roseto Degli Abruzzi,意大利)评估菌株对大肠菌素和替加环素的碳青霉烯抗性。使用分数抑制剂浓度(FIC)指数评估大黄素与替加环素联合的体外活性。结果:虽然在40株鲍曼不动杆菌菌株中只有1株对大肠粘菌素具有抗性,但6株对替加环素具有抗性。鲍曼不动杆菌菌株的MIC 50 ,MIC 90 和MIC区间对于大肠菌素分别为0.19、1.5和0.064?4μg/ ml,分别为1,8和替加环素的浓度分别为0.094?256μg/ ml。使用FIC指数未观察到协同效应。 8个菌株表现出无差异的作用,而32个表现出拮抗作用。对替加环素有抗药性的六个菌株中有三个是无差异的。其余三个是对立的。大肠菌素抗性菌株也表现出拮抗作用。结论:与它们对耐碳青霉烯类鲍曼不动杆菌的协同作用相反,粘菌素和替加环素与从VAP患者中分离得到的耐碳青霉烯类鲍曼不动杆菌菌株同时给药高度拮抗。因此,在归因于鲍曼不动杆菌的VAP的治疗期间应使用替代治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号